When focusing on miR-507, the authors were able to show the beneficial effect of its exogenous application to animals bearing A549 originating tumors (NRF2 overexpressing/KEAP1 mutated), that was demonstrated through inhibition of the tumor growth. This evidence concerns the gene KEAP1 and neoplasm.